Neuro Vigor licenses innovative Purdue technology to treat neurological diseases
April 24, 2014
An innovation to treat neurological diseases by Purdue researcher Riyi Shi has been licensed to Neuro Vigor LLC, a startup in West Lafayette. The company plans to develop and commercialize the technology, which promises to reduce the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease. (Purdue University file photo/Michel Schweinsberg)
WEST LAFAYETTE, Ind. - Neuro Vigor LLC announced Thursday (April 24) the signing of an exclusive worldwide license with Purdue Research Foundation to develop and commercialize technology that promises an innovative approach to reducing the symptoms and pain of neurological disease and injury, including multiple sclerosis, neuropathic pain and Parkinson's disease.
This pioneering technology is based on more than 15 years of research conducted at Purdue University and recently led by Neuro Vigor's co-founder and chief scientist, Riyi Shi, an internationally recognized researcher and professor of biomedical engineering and neurosciences at Purdue University.
"We are pleased to have reached a license agreement with PRF to bring the benefits of this technology to patients worldwide," Shi said. "This therapy offers strong potential to manage symptoms with more effectiveness and fewer side-effects than current treatments."
The PRF technology licensed by Neuro Vigor focuses on a novel way to reduce a toxic substance that Shi has identified as a significant contributor to neurological disease and pain. The company intends to pursue advanced pre-clinical research before beginning clinical trials and eventual patient use.
The technology is patented through the Purdue Office of Technology Commercialization, which operates one of the most comprehensive technology transfer programs among leading research universities in the United States.
About Neuro Vigor
Neuro Vigor is a privately held limited liability corporation headquartered in West Lafayette, Ind. The company was co-founded in 2013 by Dr. Riyi Shi and Mark Van Fleet, former executive director of Purdue's Global Business Engagement initiative, and a senior executive with the U.S. Chamber of Commerce. Neuro Vigor is focused on the commercialization of therapeutics and diagnostics to address diseases and disorders of the human neurological system. The company's founding team also includes David Giddings, the former president & COO of Boehringer Mannheim Corp., a leading global medical and pharmaceutical firm; chairman, president and CEO of Diametrics Medical Inc.; and CEO of Digilab Inc.
Neuro Vigor contact: Mark Van Fleet, 765-430-5559Purdue Research Foundation contact: Cynthia Sequin, 765-588-3340, email@example.com